Fig. 15
From: An overview of kinase downregulators and recent advances in discovery approaches

Artificial intelligence (AI) in kinase inhibitor discovery. AI is integrated in various technologies in a network system that can mimic human intelligence. AI is widely used in drug discovery and development, which is applied in the drug discovery and development to improve pharmaceutical products including design, synthesis, repurposing, ADMET prediction, and even the clinical trials design and monitoring